While C57BL/6 mice infected in the ear with L. major mount a vigorous Th1 response and resolve their lesions, the Th1 response in C57BL/6 mice infected with L. mexicana is more limited, resulting in chronic, non-healing lesions. The aim of this study was to determine if the limited immune response following infection with L. mexicana is related to a deficiency in the ability of monocyte-derived dendritic cells (mo-DCs) to prime a sufficient Th1 response. To address this issue we compared the early immune response following L. mexicana infection with that seen in L. major infected mice. Our data show that fewer monocytes are recruited to the lesions of L. mexicana infected mice as compared to mice infected with L. major. Moreover, monocytes that differentiate into mo-DCs in L. mexicana lesions produced less iNOS and migrated less efficiently to the draining lymph node as compared to those from L. major infected mice. Treatment of L. mexicana infected mice with α-IL-10R antibody resulted in increased recruitment of monocytes to the lesion along with greater production of IFN-γ and iNOS. Additionally, injection of DCs into the ear at the time of infection with L. mexicana also led to a more robust Th1 response. Taken together, these data suggest that during L. mexicana infection reduced recruitment, activation and subsequent migration of monocytes and mo-DCs to the draining lymph nodes may result in the insufficient priming of a Th1 response.
Leishmaniasis, caused by protozoan parasites belonging to the genus, Leishmania, exhibits clinical symptoms ranging from mild cutaneous lesions to more severe cutaneous or visceral disease. Here, we focus on L. major and L. mexicana, two species that lead to self-resolving and chronic cutaneous lesions, respectively. A strong Th1 response is necessary for resolution of disease following L. major infection. However, L. mexicana infection induces a limited Th1 response resulting in chronic disease. Monocyte-derived dendritic cells are believed to be important in priming the Th1 response during L. major infection, and therefore in this study we evaluated whether there are quantitative and/or qualitative differences in monocyte-derived dendritic cells following L. mexicana infection. We found that fewer monocytes were recruited to the lesions of L. mexicana infected mice as compared to mice infected with L. major. In addition, there were fewer iNOS producing monocyte-derived dendritic cells in the lesions of L. mexicana infected mice and less migration of monocyte-derived dendritic cells to the draining lymph node. Manipulations that allow for increased monocytes in the lesions of L. mexicana infected mice also resulted in a more robust Th1 response. Thus, these findings provide a mechanistic basis for the limited Th1 response observed during L. mexicana infection and also offer a better understanding of the important role that monocytes play during infection with Leishmania.
Citation:Petritus PM, Manzoni-de-Almeida D, Gimblet C, Gonzalez Lombana C, Scott P (2012) Leishmania mexicana Induces Limited Recruitment and Activation of Monocytes and Monocyte-Derived Dendritic Cells Early during Infection. PLoS Negl Trop Dis 6(10): e1858. doi:10.1371/journal.pntd.0001858
Editor: Judith E. Allen, University of Edinburgh, United Kingdom
Received: February 24, 2012; Accepted: August 29, 2012; Published: October 18, 2012
Copyright: © Petritus et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding:This work was supported by the National Institutes of Health Grant AI076257 (to P.S.) and Training Grant AI055400-06 (to P.M.P.). CNPq partially supported D.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Infection with Leishmania results in a variety of outcomes, depending on the parasite species and immune response mounted by the host . Murine disease models resemble human disease, with some infections being self-healing and others chronic. Resolution of leishmaniasis requires the production of IFN-γ by Th1 cells; the absence of a strong Th1 response results in chronic disease with non-healing lesions , . Th1-mediated protection is promoted by IFN-γ-induced production of nitric oxide (NO) in infected cells, which ultimately leads to parasite killing , . In C57BL/6 mice, infection with L. major results in a strong Th1 response with self-resolving lesions, in contrast, L. mexicana lesions fail to resolve . The chronic nature of L. mexicana lesions is most likely due to their inability to stimulate an effective Th1 response , , . Similarly, L. amazonensis fails to induce a strong Th1 response and leads to chronic lesions in mice , , , . However, the immune mechanisms limiting Th1 responses following either L. mexicana or L. amazonensis infection are not yet fully defined.
Several demonstrations that infection with L. mexicana suppresses IL-12 production by macrophages and dendritic cells (DCs) , ,  suggested that failure to produce IL-12 may limit the Th1 response, resulting in the observed susceptibility to L. mexicana , , . However, we found that administration of IL-12 failed to promote disease resolution, suggesting that the inability of L. mexicana mice to resolve their infection is not solely dependent upon lack of IL-12 . Therefore, we hypothesized that a more generalized deficit in DC function may contribute to the chronic lesions that develop following L. mexicana infection.
Monocyte-derived DCs (mo-DCs) play an important role in the development of protective immunity , , , . Mo-DCs differentiate from inflammatory monocytes (CD11b+, Ly6C+, CCR2+ and CX3CR1lo) recruited to sites of inflammation. Once activated, mo-DCs produce inducible nitric oxide synthase (iNOS) . Indeed, mo-DCs appear to be the major producers of iNOS during L. major infection  and are therefore likely essential for reducing the parasite burden.
In addition to iNOS production, mo-DCs contribute to immunity following infection with L. major by migrating to draining lymph nodes (dLN) where they stimulate antigen-specific Th1 T cell responses . Moreover, we recently found that L. major-activated DCs induce lymph node hypertrophy, which promotes additional recruitment of naïve T cells into the lymph node to enhance the protective response . Taken together, these data indicate that mo-DCs play an important role in the development of protective immunity to. L. major, and that a deficit in their recruitment or activation might limit a protective Th1 response.
In the present study, we investigated whether the meager Th1 response observed during L. mexicana infection is due to limitations in the: 1) recruitment of monocytes from the blood to the site of infection; 2) differentiation of monocytes into iNOS-producing mo-DCs; and/or 3) migration to the draining lymph node. We found that monocyte recruitment to the site of infection was reduced in L. mexicana infected mice compared to L. major infected mice. Moreover, while monocytes in L. mexicana lesions upregulated expression of CD11c, they produced significantly less iNOS and migrated less efficiently to the draining lymph node relative to monocytes in L. major infected mice. Following treatment of L. mexicana infected mice with α-IL-10R antibody, there was increased recruitment of monocytes to the lesion, as well as increased production of IFN-γ and iNOS. Additionally, when DCs were injected into the ear at the time of infection with L. mexicana, there was a more robust Th1 response. These data imply that the poor Th1 response observed during L. mexicana infection results from both reduced monocyte recruitment to the lesions, and a relative deficit in their differentiation into functional effector populations.
Materials and Methods
All animal studies were carried out in compliance with the guidelines of the Institutional Animal Care and Use Committee (IACUC) of the University of Pennsylvania and in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The animal protocol was approved by the IACUC of the University of Pennsylvania, Philadelphia PA.
Mice, Parasites and Infections
Female C57BL/6 (B6) and B6-Ly5.2/Cr (CD45.1) mice were purchased from the National Cancer Institute (Fredricksburg, MD). Animals were maintained and experiments were carried out in a specific pathogen-free environment. L. major V1 parasites (MHOM/IL/80/Friedlin) or L. mexicana parasites (MNYC/BZ/62/M379) were grown until stationary phase in Schneider's Drosophila medium (Gibco, Grand Island, NY) supplemented with 20% heat-inactivated FBS (Gibco) and 2 mM l-glutamine (Sigma). Metacyclic promastigotes were isolated by density gradient . For infection of mice, 1×105 metacyclic parasites were injected into the ear.
For flow cytometry, cells were isolated from ears or draining lymph nodes. Dermal ear sheets were separated and incubated in Liberase TL (Roche, Indianapolis, IN) for 1 hr at 37°C. Ears and draining lymph nodes were made into single cell suspensions and washed with PBS. Fixable Aqua dye (Invitrogen, Carlsbad, CA) was added to assess cell viability. Cells were then incubated with Block (CD16/32, inactivated mouse sera and Rat IgG) followed by fluorochrome-conjugated antibodies for surface markers (CD11c, CD11b, CD45.1, CD45.2, MHCII (e-Bioscience, San Diego, CA), and Ly6C (BD Pharmingen, San Diego, CA). Intracellular staining was performed for iNOS using an unconjugated anti-iNOS/NOS II rabbit polyclonal IgG (Millipore, Temecula, CA) followed by flourochrome-conjugated donkey-anti-rabbit IgG (e-Bioscience). Briefly, surface-stained cells were fixed in PBS with 2% paraformaldehyde and then permeabilized with 0.2% saponin in FACS staining buffer (PBS containing 0.1% BSA). Cells were fixed by using 2% paraformaldehyde and samples were acquired on a FACS Canto flow cytometer (BD Pharmingen). Analysis was performed using FlowJo software (Tree Star, Ashland, OR).
Monocyte purification and transfer
Bone marrow was harvested from tibias and femurs of naïve mice. Following lysis of red blood cells with ACK lysis buffer (Lonza, Walkersville, MD), Miltenyi MACS columns were used to purify monocytes. Briefly, anti-Ly6G-biotin antibody and biotin microbeads (Miltenyi, Auburn, MD) were added to the cells, which were then placed over a LS column. Ly6G+ cells on the column were discarded and anti-PE CD11b (e-Bioscience) and PE microbeads were added to the flow through, which was placed over a 2nd LS column. CD11b+ cells attached to the column were washed off. Monocytes were enriched to 50% as evaluated by flow cytometry. 1×106 total cells from the final column were transferred into mice by intradermal injection into the lesions.
Mice were anesthetized using ketamine/xylazine and the ventral side of each ear was painted with FITC isomer (Sigma, St. Louis, MO). FITC (8 mg/mL) was dissolved in an equal volume of acetone and dibutyl phthalate (Sigma) and 25 µL of the mixture was applied to the skin. Migration of FITC+ cells was assessed in the draining lymph node 48 hours following application.
Mice were injected intraperitoneally with 500 µg of α-IL-10R antibody (1B1.3A, BioXcell, West Lebanon, NH) one day prior to intradermal infections of 1×105 L. mexicana metacyclics in both ears. Mice were subsequently treated with 500 µg of α-IL-10R antibody on day 3 and then 250 µg every 3 days until the final harvest at 2 weeks post-infection.
Supernatants from draining lymph node cultures stimulated with L. mexicana freeze-thaw antigen for 72 hrs were collected and assayed by sandwich ELISA using paired monoclonal antibody to detect IFN-γ.
Generation of dendritic cells and transfer
DCs were generated as previously described . Briefly, bone marrow cells from C57BL/6 mice were isolated from femurs and tibias of mice by syringe flushing. Bone marrow cells were counted and seeded into 6-well plates at 5×105 cells/mL in 3 mLs of media - RPMI 1640 (Gibco) supplemented with 10% heat-inactivated FBS (Gibco), 2 mM glutamine (Sigma), 50 µM 2-ME (Gibco), 100 U/mL penicillin (Sigma), 100 µg/mL streptomycin (Sigma) and 20 ng/mL GM-CSF (Peprotech, Rocky Hill, NJ) per well. Cells were maintained at 37°C with 5% CO2 and fed on days 3, 6 and 8 with 3 mLs of fresh media. Cells were harvested on day 10 and injected into the ear of C57BL/6 mice at the time of infection. Briefly, 1×106 DCs and 1×105 L. mexicana metacyclics were mixed immediately prior to injecting into the ear.
Statistical significance was determined using unpaired, two-tailed Student's t test. Results with a p value ≤0.05 were considered significant.
Fewer monocytes are recruited during infection with Leishmania mexicana compared to L. major
The development of a protective response following L. major infection is associated with the recruitment of monocytes into the lesion, which are believed to differentiate into mo-DCs (defined as CD11bhi, CD11c+, Ly6C+) to prime a strong Th1 response . Since L. mexicana infection promotes chronic, non-healing lesions and a minimal Th1 response, we hypothesized that fewer monocytes would be recruited to lesions following infection with L. mexicana compared to L. major. To test this, we infected C57BL/6 mice with either L. major or L. mexicana parasites and assessed the cellular composition of the lesions at 3 and 14 days post-infection. Expression of CD11b, a subunit of αMβ2 (also known as Mac-1 and CR3), was used to detect infiltrating leukocyte populations, including monocytes, macrophages, and granulocytes . At 3 days post-infection, there was a significant increase in the percentage of CD11bhi cells in dermal lesions from L. major infected mice compared to normal skin (Fig. 1A). In contrast, no increase in CD11bhi cells was observed in lesions from L. mexicana infected mice. Moreover, the difference in percentage of CD11bhi cells between L. major and L. mexicana lesions was still evident two weeks after infection (Fig. 1A). In contrast, neutrophil (CD11bhi Ly6G+) frequency increased equally in lesions of both L. major and L. mexicana infected mice by day 14 as compared to normal skin (data not shown). Consistent with the observed alterations in CD11bhi cells, there was an increase in inflammatory monocytes (CD11bhi CD11c− Ly6C+) in the lesions from 3-day and 14-day L. major infected mice as compared with normal skin (Fig. 1B) while no such increase was observed following L. mexicana infection (Fig. 1B). By day 14, mo-DCs (CD11bhi CD11c+ Ly6C+) were evident in lesions of both L. major and L. mexicana infected mice, however, mo-DCs were preferentially represented in L. major lesions (Fig. 1C). Taken together, these results suggest that L. mexicana fails to promote the recruitment of monocytes, reducing the number of cells available for subsequent differentiation into mo-DCs capable of controlling parasite numbers.
Ears from naïve, as well as L. major or L. mexicana infected C57BL/6 mice were processed to single cell suspensions. (A) Percentage of CD11bhi cells present in the ear of naïve or infected mice on day 3 and 14. Cells are previously gated on total, single live cells. Histograms of monocytes (B) or mo-DCs (C) in the ear of naïve (grey shaded histogram) or infected mice (black line) on day 3 and 14 and absolute number of monocytes (B) or mo-DCs (C) from naïve, day 3 and day 14 infected mice. Monocytes are pre-gated on CD11bhi CD11c− cells and mo-DCs are previously gated on CD11bhi CD11c+ cells. The results expressed are the mean percentage (± SD for FACS plots) or the mean number of cells (± SE for bar graphs) of 3 mice per group. The results are representative of two experiments. * significantly lower (p<0.05) compared to L. major infected mice in Fig. 1A or p<0.05 between indicated groups in Fig. 1B and C.
L. mexicana lesions have fewer iNOS producing mo-DCs compared to L. major
Although there were fewer monocytes recruited to lesions from L. mexicana infected mice compared with those from L. major infected mice, the ratio of monocytes to mo-DCs was similar (Fig. 2). In these experiments we did not determine if the CD11c+ Ly6C+ cells were derived from monocytes, but based on previous findings , this is our assumption. However, mo-DCs in the lesions from L. mexicana infected mice expressed significantly less iNOS compared with mo-DCs from L. major lesions. Thus, while approximately 20% of the mo-DCs in lesions from L. major infected mice were iNOS+, only 3% were iNOS+ in lesions from L. mexicana infected mice (Fig. 3A). Similarly, the number of iNOS-producing mo-DCs was significantly reduced in lesions from mice infected with L. mexicana (Fig. 3B). CD11bhi CD11c− Ly6C+, inflammatory monocytes, did not make iNOS in either L. major or L. mexicana infected mice (data not shown). These data demonstrate that there are fewer iNOS-producing mo-DCs in L. mexicana infected mice, potentially contributing to the inability of these mice to resolve their infection.
C57BL/6 mice were infected in the ear with L. major or L. mexicana and ears were processed as above. Percentage of monocytes and mo-DCs on day 3 and 14 were used to determine a ratio of differentiation from monocytes to mo-DCs in L. major or L. mexicana infected mice. The results expressed are the mean ratio (± SE) of 3 mice per group. The results are representative of two experiments.
C57BL/6 mice were infected and ears were processed as above. In addition to staining for surface markers, intracellular staining for iNOS was performed. Percentage (A) or absolute number (B) of iNOS-producing cells in the ear of naïve or infected mice on day 14. Cells are previously gated on live, singlets that are CD11bhi CD11c+. The results expressed are the mean percentage (± SD for FACS plots) or the mean number of cells (± SE for the bar graph) of 3 mice per group. The results are representative of two experiments. * significantly lower (p<0.05) compared to L. major infected mice.
Migration of mo-DCs from lesions to the draining lymph node occurs less efficiently during L. mexicana infection compared to L. major
In addition to killing parasites at the site of infection through iNOS-dependent mechanisms, mo-DCs also migrate to dLNs where they orchestrate the developing immune response through antigen presentation and regulation of cytokine production . Recently, we have also shown that L. major-activated DCs promote lymph node hypertrophy following infection  and the impaired lymph node expansion following L. mexicana infection  led us to investigate if a reduction in mo-DCs migration to the draining lymph node during L. mexicana infection limits the Th1 response and impairs lymph node expansion.
To evaluate the ability of DCs to migrate from the site of infection, C57BL/6 mice were infected in the ear with L. major or L. mexicana and two weeks post-infection the ears were FITC painted. After 48 hours we compared the FITC+ DCs (CD11c+ MHCIIhi) in the draining lymph node from naïve, L. major infected or L. mexicana infected mice. Notably, there were significantly more FITC+ DCs in L. major infected mice when compared to either naïve or L. mexicana infected mice. In contrast, there was no difference in the number of FITC+ DCs between naïve and L. mexicana infected mice (Fig. 4), indicating that mo-DCs migration to the dLN is compromised in L. mexicana infected mice.
C57BL/6 mice were infected as above for two weeks. FITC isomer was applied to the ears of naïve, L. major or L. mexicana infected mice on day 14 and dLNs were harvested and processed forty-eight hours later. FITC+ MHCIIhi CD11c+ cells were enumerated in the dLNs. These cells are previously gated on live, singlets that are CD11bhi. The results expressed are the mean number of cells (± SE) of 3 mice per group. The results are representative of two experiments. * significantly different (p<0.05) between indicated groups.
We next wanted to determine if the microenvironment within L. mexicana lesions actively inhibited DC migration. Therefore, we injected the same number of CD45 disparate monocytes into L. major or L. mexicana lesions and evaluated their migration to the draining lymph node. Figure 5A shows an equivalent number of CD11b+ CD45.1+ cells in the ear of L. major or L. mexicana infected mice approximately 18 hours following monocyte transfer. Interestingly, the expression of Ly6C on the donor monocytes was lower in L. major infected mice as compared to L. mexicana infected mice (Fig. 5B). As downregulation of Ly6C is associated with activation of mo-DCs , , these data suggest that mo-DCs in L. mexicana infected mice do not differentiate as efficiently as mo-DCs from L. major infected mice. Even more strikingly, there is a dramatic increase in both the frequency and absolute number of transferred cells in the draining lymph node of L. major infected as compared to L. mexicana infected mice (Fig. 5C and D), indicating that L. mexicana infection does not increase mo-DC trafficking to dLNs. However, we cannot exclude the possibility that there may be a difference in retention in the dLN of L. major versus L. mexicana infected mice. Together, these data indicate that a lack of mo-DCs migration from the site of L. mexicana infection to the draining lymph node may prevent T cell priming and impair lymph node expansion, precluding the induction of a protective Th1 response and resulting in the development of chronic disease.
Monocytes enriched from CD45.1 C57BL/6 mice were injected into the ear of CD45.2 C57BL/6 mice that were infected for two weeks with either L. major or L. mexicana. Eighteen hours following injection of the monocytes, ears and dLNs were harvested and processed. (A) Absolute number of transferred monocytes (CD11b+ CD45.1+) in the ear. Cells are previously gated on total, live cells that are singlets. (B) Mean fluorescence intensity (MFI) of Ly6C on transferred cells recovered from the ears of infected mice. Percentage (C) or absolute number (D) of CD45.1+ cells in the dLN. These cells are previously gated on live, singlets that are CD11bhi cells. The results expressed are the mean percentage (± SD for FACS plots) or the mean number of cells (± SE for bar graphs) of 3 mice per group. The results are representative of two experiments. * significantly different (p<0.05) compared to L. major infected mice.
IL-10 limits monocyte recruitment during infection with L. mexicana
IL-10 has been described as having anti-inflammatory effects during infection by inhibiting cytokine production and antigen presentation , however, more recently it was shown that IL-10 also limits recruitment of CD11b+ Ly6C+ monocytes following T. brucei infection . Since IL-10−/− mice infected with L. mexicana resolve their lesions , we wanted to investigate whether blocking interaction of IL-10 with its receptor would lead to increased monocyte recruitment. We infected C57BL/6 mice as before with L. mexicana and treated one group with α-IL-10R antibody. We evaluated monocyte recruitment to lesions on days 7 and 14 following infection and found that there was a greater percentage and number of monocytes recruited to L. mexicana lesions in mice treated with α-IL-10R (Fig. 6A). Similarly, the percentage and number of mo-DCs in the lesions of L. mexicana infected mice was also significantly increased when IL-10R was blocked (Fig. 6A). Moreover, there were increased levels of IFN-γ in the draining lymph nodes (Fig. 6B), as well as a greater percentage and number of iNOS-producing mo-DCs in the lesions of L. mexicana infected mice treated with α-IL-10R (Fig. 6C). These data suggest that IL-10 is a key factor contributing to the limited number of monocytes observed during L. mexicana infection since blocking the interaction of IL-10 with its receptor results in a dramatic increase in monocytes and mo-DCs in the lesion. Surprisingly, we did not see a difference in the parasite burden in treated and untreated L. mexicana infected mice at this early time point, in spite of the fact that we have previously shown that IL-10−/− mice eventually resolve their L. mexicana lesions . Our assumption is that the effect on parasite burden is simply delayed and will develop later.
Ears from naïve, L. mexicana infected or L. mexicana infected and α-IL-10R treated C57BL/6 mice were processed as above. (A) Histograms of monocytes on day 7 and 14 or mo-DCs on day 14 in the ear of naïve (grey shaded histogram), L. mexicana infected mice (black line, top) or L. mexicana infected and α-IL-10R treated mice (black line, bottom). Absolute numbers of monocytes and mo-DCs are also shown. Monocytes are previously gated on live, singlets that are CD11bhi CD11c−. Mo-DCs are previously gated on live, singlets that are CD11bhi CD11c+. (B) Levels of IFN-γ (ng/mL) from the supernatants of single cell suspensions from the dLN of each group that were stimulated for 72 hours with L. mexicana freeze-thaw antigen. (C) Percentage and absolute number of iNOS-producing cells in the ear of naïve, L. mexicana infected mice or L. mexicana infected and α-IL-10R treated mice on day 14. Cells are previously gated on live, singlets that are CD11bhi CD11c+. The results expressed are the mean percentage (± SD for FACS plots) or the mean number of cells (± SE for bar graphs) of 3–5 mice per group. The results are representative of two experiments. * significantly higher (p<0.05) compared to L. mexicana infected mice in Fig. 6A and 6C (FACS plots) or p<0.05 between indicated groups in Fig. 6A, 6B and 6C (bar graphs).
Injecting DCs into the ear at the time of infection with L. mexicana results in a more robust Th1 response
The previous experiment, where L. mexicana infected mice were treated with α-IL-10R antibody, suggests that the increase in mo-DCs in the lesion may result in the priming of an improved Th1 response. Here, we test whether there is a correlation between increased numbers of DCs in the lesion and a more robust Th1 response. We injected DCs into the ear at the time of infection with L. mexicana and we compared the Th1 response 14 days post-infection to L. mexicana infected mice receiving no DCs. As predicted, L. mexicana infected mice receiving DCs produced greater levels of IFN-γ (Fig. 7A), and had a greater percentage and number of iNOS-producing DCs (Fig. 7B). Moreover, the impaired lymph node expansion that occurs during infection with L. mexicana was overcome in mice that received DCs (Fig. 7C). Taken together, these data suggest that the limited Th1 response observed in L. mexicana infected mice can be overcome if a greater number of DCs can be established in the lesion.
C57BL/6 mice were infected as before in the ear with L. mexicana, however, one group also received DCs that were derived in vitro. At two weeks post-infection ears and dLNs were processed. (A) Levels of IFN-γ (ng/mL) from the supernatants of single cell suspensions from the dLN of each group that were stimulated for 72 hours with L. mexicana freeze-thaw antigen. (B) Percentage and absolute number of iNOS-producing cells in the ear of L. mexicana infected mice or L. mexicana infected mice that received DCs. Cells are previously gated on live, singlets that are CD11bhi CD11c+. (C) The cellularity of the dLN in L. mexicana infected mice or L. mexicana infected mice that received DCs. The results expressed are the mean percentage (± SD for FACS plots) or the mean number of cells (± SE for bar graphs) of 2–4 mice per group. The results are representative of two experiments. * significantly higher (p<0.05) compared to L. mexicana infected mice.
Infection of C57BL/6 mice with either L. major or L. mexicana results in cutaneous lesions. However, while L. major-induced lesions heal, those induced by L. mexicana infection do not. The chronicity of L. mexicana infections is attributable to the limited Th1 response mounted by the host to the parasite , , . Since the development of a Th1 response in leishmaniasis depends upon IL-12 production by DCs , , , , it was originally thought that L. mexicana fails to induce a healing response due to its inability to stimulate IL-12 production , , , . However, the limited Th1 response in L. mexicana infected mice is not reversed by treatment with rIL-12 , suggesting that there is a more generalized impairment in DC function.
Differentiation of mo-DCs from inflammatory monocytes at the site of infection plays an essential role in immune protection in a number of infectious diseases , . Monocytes are recruited to L. major infected skin , ,  and mo-DCs are thought to be essential for the induction of the Th1 response in L. major infection , suggesting that limitations in monocyte recruitment and differentiation (or both) may lead to chronic disease following L. mexicana infection. In support, our current studies demonstrate that fewer monocytes are recruited during infection with L. mexicana when compared to L. major, and the consequent reduction in differentiated mo-DCs present in L. mexicana lesions likely compromises generation of a protective Th1 response. In addition, reduced monocyte recruitment and the observed decrease in iNOS expression will limit the killing capacity of these cells , presumably leading over time to increased parasite burden. Together, the limited Th1 response and enhanced parasite burden could promote the chronic exacerbated disease observed following L. mexicana infection.
The importance of monocyte recruitment in limiting the progression of infectious diseases has been most clearly demonstrated in CCR2 deficient (CCR2−/−) mice. CCR2 is a chemokine receptor expressed on inflammatory monocytes that mediates monocyte chemotaxis. In CCR2−/− mice, Ly6Chi monocytes accumulate in the bone marrow due to their inability to emigrate from this site. Limited recruitment of monocytes to the site of infection likely contributes to the enhanced susceptibility of CCR2−/− mice to Listeria infection . In addition, following oral Toxoplasma gondii infection of CCR2−/− mice, monocytes fail to be recruited to the illeum, allowing for uncontrolled parasite growth. However, adoptive transfer of CCR2-expressing monocytes into T. gondii infected CCR2−/− mice protected them from this otherwise lethal infection . CCR2−/− mice infected with L. major are also more susceptible to infection due to an attenuated Th1 response . Interestingly, treatment of CCR2−/− mice with rIL-12 is able to reverse the susceptibility to L. major infection . Since mo-DCs have been described as the major producers of IL-12 during L. major infection , these data support our hypothesis that compromised recruitment of monocytes to the lesion influences the development of a Th1 response in L. mexicana infected mice.
As IL-10 has been shown to limit the recruitment of CD11b+ Ly6C+ monocytes during infection with T. brucei  and we have previously shown that IL-10−/− mice infected with L. mexicana resolve their lesions , we hypothesized that monocyte recruitment following L. mexicana infection is impacted by IL-10 production at the lesion site. In fact, we showed that by blocking IL-10R, there was increased recruitment of CD11bhi Ly6C+ monocytes to L. mexicana infected lesions. Moreover, L. mexicana infected mice treated with α-IL-10R produced significantly more iNOS and IFN-γ than L. mexicana infected C57BL/6 mice. As during T. brucei infection , it is likely that production of IL-10 in L. mexicana-induced lesions may work on several levels. IL-10 could lead to decreased levels of CCL2, which would explain the limited recruitment of monocytes into the lesions. IL-10 is also capable of dampening Th1 responses, which would result in lower levels of iNOS and IFN-γ. Therefore, these data provide a mechanism as to why there is limited recruitment of monocytes to the lesion during infection with L. mexicana.
Finally, while DCs are clearly needed to prime T cells in the draining lymph node, they also promote lymph node hypertrophy. We previously demonstrated that lymph node hypertrophy is associated with the protective response to L. major infection  and have more recently revealed that L. major-activated DCs are responsible for lymph node expansion . During infection with L. mexicana, lymph node hypertrophy is greatly reduced, potentially limiting the immune response . Here we have used two methods to track migration of mo-DCs from the lesion to the draining lymph node; one method marked endogenous mo-DCs in the lesion and the other utilized injection of CD45 disparate monocytes directly into the lesion. While fewer endogenous mo-DCs from the L. mexicana lesion migrated to the dLN as compared to L. major, this may have been due to the relatively low numbers of monocytes initially present within the lesions of L. mexicana infected mice. To address this problem, we injected equal numbers of monocytes into L. major or L. mexicana lesions, and found that there was still a deficit in the migration of mo-DCs to the dLN from L. mexicana lesions. An inability of mo-DCs to migrate to the dLN could prevent both antigen-specific responses, as well as mo-DC-driven lymph node hypertrophy, providing a potential explanation for the reduction in lymph node size in L. mexicana infected mice. Interestingly, if DCs are injected into the ear at the same time of infection with L. mexicana, mice have significantly larger lymph nodes and are able to mount a more robust Th1 response compared to mice that did not receive DCs. These data clearly demonstrate that mo-DCs are important in initiating an appropriate immune response against Leishmania and that the limited recruitment of monocytes observed during L. mexicana infection could lead to the chronic nature of the disease.
In summary, we have demonstrated that 1) fewer monocytes are recruited to lesion during infection with L. mexicana as compared to L. major, 2) fewer iNOS producing mo-DCs are present in the lesions of L. mexicana infected mice 3) fewer mo-DCs migrate to the dLN node during L. mexicana infection, 4) blocking IL-10R leads to increased monocyte recruitment and a more robust Th1 response during L. mexicana infection, and 5) injection of DCs into the ear at the time of infection with L. mexicana also leads to increased levels of iNOS and IFN-γ. Together, these findings provide a mechanistic basis for the limited Th1 response, and lack of lymph node hypertrophy observed in L. mexicana infected mice and offer a better understanding of the important role that monocytes play during infection with Leishmania.
Conceived and designed the experiments: PMP CG CGL PS. Performed the experiments: PMP DM CG. Analyzed the data: PMP CG. Wrote the paper: PMP PS.
- 1. McMahon-Pratt D, Alexander J (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206–224. doi: 10.1111/j.0105-2896.2004.00190.x
- 2. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annual review of immunology 13: 151–177. doi: 10.1146/annurev.iy.13.040195.001055
- 3. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nature reviews Immunology 2: 845–858. doi: 10.1038/nri933
- 4. Alexander J, Kaye PM (1985) Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Clinical and experimental immunology 61: 674–682.
- 5. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, et al. (2003) Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. journal of immunology 171: 3711–3717.
- 6. Buxbaum LU, Scott P (2005) Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infection and immunity 73: 2101–2108. doi: 10.1128/iai.73.4.2101-2108.2005
- 7. Ji J, Sun J, Soong L (2003) Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun 71: 4278–4288. doi: 10.1128/iai.71.8.4278-4288.2003
- 8. Afonso LC, Scott P (1993) Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952–2959.
- 9. Jones DE, Buxbaum LU, Scott P (2000) IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol 165: 364–372.
- 10. Qi H, Popov V, Soong L (2001) Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J Immunol 167: 4534–4542.
- 11. Bennett CL, Misslitz A, Colledge L, Aebischer T, Blackburn CC (2001) Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur J Immunol 31: 876–883. doi: 10.1002/1521-4141(200103)31:3<876::aid-immu876>3.0.co;2-i
- 12. Weinheber N, Wolfram M, Harbecke D, Aebischer T (1998) Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol 28: 2467–2477. doi: 10.1002/(sici)1521-4141(199808)28:08<2467::aid-immu2467>3.3.co;2-t
- 13. Alexander J, Satoskar AR, Russell DG (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112 Pt 18: 2993–3002.
- 14. Rodriguez-Sosa M, Monteforte GM, Satoskar AR (2001) Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness. Immunol Cell Biol 79: 320–322. doi: 10.1046/j.1440-1711.2001.01014.x
- 15. Satoskar A, Bluethmann H, Alexander J (1995) Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun 63: 4894–4899.
- 16. Stamm LM, Raisanen-Sokolowski A, Okano M, Russell ME, David JR, et al. (1998) Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J Immunol 161: 6180–6188.
- 17. Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P (2002) Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol 32: 3206–3215. doi: 10.1002/1521-4141(200211)32:11<3206::aid-immu3206>3.0.co;2-j
- 18. Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nature reviews Immunology 11: 762–774. doi: 10.1038/nri3070
- 19. Serbina NV, Jia T, Hohl TM, Pamer EG (2008) Monocyte-mediated defense against microbial pathogens. Annual review of immunology 26: 421–452. doi: 10.1146/annurev.immunol.26.021607.090326
- 20. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annual review of immunology 27: 669–692. doi: 10.1146/annurev.immunol.021908.132557
- 21. Rivollier A, He J, Kole A, Valatas V, Kelsall BL (2012) Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209: 139–155. doi: 10.1084/jem.20101387
- 22. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59–70. doi: 10.1016/s1074-7613(03)00171-7
- 23. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. (2009) iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog 5: e1000494. doi: 10.1371/journal.ppat.1000494
- 24. Leon B, Lopez-Bravo M, Ardavin C (2007) Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26: 519–531. doi: 10.1016/j.immuni.2007.01.017
- 25. Carvalho LP, Petritus PM, Trochtenberg AL, Zaph C, Hill DA, et al. (2011) Lymph Node Hypertrophy following Leishmania major Infection Is Dependent on TLR9. J Immunol doi: 10.4049/jimmunol.1101018
- 26. Spath GF, Beverley SM (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97–103. doi: 10.1006/expr.2001.4656
- 27. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77–92. doi: 10.1016/s0022-1759(98)00204-x
- 28. Solovjov DA, Pluskota E, Plow EF (2005) Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 280: 1336–1345. doi: 10.1074/jbc.m406968200
- 29. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252. doi: 10.1038/32588
- 30. Hsu AC, Scott P (2007) Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J Immunol 179: 8200–8207.
- 31. Leon B, Martinez del Hoyo G, Parrillas V, Vargas HH, Sanchez-Mateos P, et al. (2004) Dendritic cell differentiation potential of mouse monocytes: monocytes represent immediate precursors of CD8− and CD8+ splenic dendritic cells. Blood 103: 2668–2676. doi: 10.1182/blood-2003-01-0286
- 32. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annual review of immunology 19: 683–765. doi: 10.1146/annurev.immunol.19.1.683
- 33. Bosschaerts T, Guilliams M, Stijlemans B, Morias Y, Engel D, et al. (2010) Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling. PLoS Pathog 6: e1001045. doi: 10.1371/journal.ppat.1001045
- 34. Satoskar A, Alexander J (1995) Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana. Immunology 84: 1–4.
- 35. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. The Journal of experimental medicine 177: 1505–1509. doi: 10.1084/jem.177.5.1505
- 36. Heinzel FP (1994) Interleukin 12 and the regulation of CD4+ T-cell subset responses during murine Leishmaniasis. Parasitology today 10: 190–192. doi: 10.1016/0169-4758(94)90028-0
- 37. Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, et al. (1994) The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235–237. doi: 10.1126/science.7904381
- 38. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177: 1797–1802. doi: 10.1084/jem.177.6.1797
- 39. Goncalves R, Zhang X, Cohen H, Debrabant A, Mosser DM (2011) Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J Exp Med 208: 1253–1265. doi: 10.1084/jem.20101751
- 40. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nature immunology 7: 311–317. doi: 10.1038/ni1309
- 41. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, et al. (2008) Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29: 306–317. doi: 10.1016/j.immuni.2008.05.019
- 42. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, et al. (2000) CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192: 205–218. doi: 10.1084/jem.192.2.205
- 43. Jimenez F, Quinones MP, Martinez HG, Estrada CA, Clark K, et al. (2010) CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J Immunol 184: 5571–5581. doi: 10.4049/jimmunol.0803494